News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,010 Results
Type
Article (14467)
Company Profile (114)
Press Release (351429)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112675)
Career Advice (456)
Deals (18615)
Drug Delivery (29)
Drug Development (31182)
Employer Resources (50)
FDA (8795)
Job Trends (7676)
News (172805)
Policy (12366)
Tag
Academia (1325)
Accelerated approval (3)
Allergies (42)
Alliances (34842)
ALS (27)
Alzheimer's disease (519)
Antibody-drug conjugate (ADC) (81)
Approvals (8829)
Artificial intelligence (254)
Autoimmune disease (5)
Automation (13)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1088)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (110)
Cell therapy (282)
Cervical cancer (11)
Clinical research (24553)
Collaboration (633)
Compensation (118)
Complete response letters (3)
COVID-19 (1148)
CRISPR (41)
C-suite (153)
Cystic fibrosis (47)
Data (1057)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4928)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38972)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51599)
Executive appointments (422)
FDA (9521)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (498)
Gene editing (94)
Generative AI (24)
Gene therapy (184)
GLP-1 (230)
Government (1235)
Grass and pollen (2)
Guidances (84)
Healthcare (9897)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1226)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8019)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (119)
Leadership (3)
Legal (2523)
Liver cancer (36)
Lung cancer (130)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (198)
MASH (16)
Medical device (11508)
Medtech (11513)
Mergers & acquisitions (10965)
Metabolic disorders (227)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (32)
Neuropsychiatric disorders (4)
Neuroscience (723)
NextGen: Class of 2025 (3535)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (77)
Ovarian cancer (41)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (68)
Partnered (12)
Patents (155)
Patient recruitment (59)
Peanut (26)
People (32825)
Pharmaceutical (16)
Phase I (9055)
Phase II (11079)
Phase III (7182)
Pipeline (652)
Policy (32)
Postmarket research (501)
Preclinical (4111)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (138)
Real estate (3366)
Recruiting (20)
Regulatory (9428)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2508)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (327)
Venture capitalists (19)
Weight loss (36)
Women's health (18)
Worklife (2)
Date
Today (96)
Last 7 days (465)
Last 30 days (1575)
Last 365 days (17003)
2025 (6059)
2024 (18710)
2023 (22099)
2022 (30813)
2021 (32514)
2020 (30545)
2019 (25809)
2018 (19470)
2017 (18877)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12743)
2012 (13783)
2011 (14071)
2010 (12831)
Location
Africa (318)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24118)
Australia (4194)
California (3097)
Canada (1080)
China (256)
Colorado (174)
Connecticut (133)
Delaware (49)
Europe (49304)
Florida (510)
Georgia (141)
Idaho (33)
Illinois (295)
India (13)
Indiana (169)
Iowa (5)
Japan (125)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (478)
Massachusetts (2148)
Michigan (189)
Minnesota (261)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (25)
New Hampshire (67)
New Jersey (962)
New Mexico (16)
New York (904)
North Carolina (550)
North Dakota (8)
Northern California (1174)
Ohio (106)
Oklahoma (11)
Oregon (20)
Pennsylvania (629)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (23)
South Dakota (1)
Southern California (1272)
Tennessee (64)
Texas (500)
United States (12201)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
366,010 Results for "palatin technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin Technologies Announces Closing of Reduced Public Offering
May 9, 2025
·
5 min read
Press Releases
Palatin Technologies Announces Pricing of up to $23 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025
May 9, 2025
·
5 min read
Press Releases
Palatin Expects $11.5 Million Financing to Cure NYSE American Delisting Notice
May 7, 2025
·
3 min read
Press Releases
Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy
May 5, 2025
·
5 min read
Press Releases
Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025
May 8, 2025
·
7 min read
Press Releases
Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
April 29, 2025
·
9 min read
Press Releases
Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
April 17, 2025
·
6 min read
Press Releases
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
April 11, 2025
·
7 min read
Press Releases
Palatin Provides Update on Anticipated 2025 Corporate Milestones
January 28, 2025
·
6 min read
1 of 36,601
Next
